Compare MMED & CNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MMED | CNS |
|---|---|---|
| Founded | 1983 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 3.7B |
| IPO Year | 2026 | 2004 |
| Metric | MMED | CNS |
|---|---|---|
| Price | $14.91 | $73.75 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 2 |
| Target Price | $22.56 | ★ $71.50 |
| AVG Volume (30 Days) | ★ 818.9K | 200.1K |
| Earning Date | 06-03-2026 | 04-16-2026 |
| Dividend Yield | N/A | ★ 3.96% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.82 |
| Revenue | N/A | ★ $427,536,000.00 |
| Revenue This Year | $15.99 | $4.71 |
| Revenue Next Year | $10.00 | $4.37 |
| P/E Ratio | ★ N/A | $90.17 |
| Revenue Growth | N/A | ★ 4.07 |
| 52 Week Low | $10.65 | $58.39 |
| 52 Week High | $17.86 | $78.81 |
| Indicator | MMED | CNS |
|---|---|---|
| Relative Strength Index (RSI) | 68.38 | 64.18 |
| Support Level | $10.68 | $59.88 |
| Resistance Level | $15.80 | $77.18 |
| Average True Range (ATR) | 0.88 | 1.85 |
| MACD | 0.49 | 0.11 |
| Stochastic Oscillator | 93.83 | 86.50 |
Minimed Group Inc is a medical technology firm that develops, manufactures, and markets products and solutions for diabetes management. It offers automated insulin pumps, continuous glucose monitoring systems and sensors, and smart insulin pens as its main products. The company sells these through direct-to-consumer channels and healthcare providers of various countries. The company's revenues are principally derived from the sale of reusable and single-use products which together comprise AID systems and smart multiple daily injection (MDI) systems for diabetes management to individuals, distributors, healthcare providers, and other institutions globally.
Cohen & Steers is a niche asset manager concentrating on real estate securities. The firm invests mainly in the equity shares of real estate investment trusts, with holdings in domestic and international real estate securities accounting for around two-thirds of its $98.4 billion in managed assets at the end of February. Cohen & Steers also manages portfolios dedicated to preferred securities, utilities stocks, and other high-yield offerings. The firm's distribution is balanced among its closed-end funds, open-end funds, and institutional accounts. During the past four calendar quarters, the company garnered 39% (25%) of its managed assets (base management fees) from institutional clients, 48% (55%) from open-end funds, and 13% (20%) from closed-end funds.